10P Lung immune prognostic index (LIPI) predicts response to immune checkpoint inhibitors in NSCLC patients by Izquierdo Tolosa, C.D., Ramos Ramirez, M., Cabrera Miranda, L.A., Caballe Perez, E., Regino, A., Lozano-Vazquez, N., Arrieta Rodriguez, O.G.

Get full text

3MO Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutant advanced NSCLC after progression on osimertinib: A post-progression analysis of MARIPOSA-2 by Gentzler, R.D., Spira, A., Melosky, B., Owen, S., Burns, T., Massarelli, E., Nagasaka, M., Fang, B., Sanborn, R.E., Rodriguez, O.G. Arrieta, Card, C., Cappuzzo, F., Xia, K., Chu, P-L., Shah, S., Diorio, B., Garvin, A., Mahadevia, P., Bauml, J.M., Reckamp, K.

Get full text

P2.09-28 Prognostic Impact of LKB1 Expression in Advanced Non-Small-Cell Lung Cancer by Diaz-Garcia, D.A., Tirado, L.A. Ramírez, Aviles-Salas, A., Cardona, A.F., Rodriguez-Rios, A., Barrón, F., Arrieta, O.G.

Get full text

EP1.04-44 Exploration of Factors Relating to Paradoxical Immune Response in Patients Treated with Immune Checkpoint Inhibitors for NSCLC by Cardona, A.F., Arrieta, O.G., Ruiz-Patiño, A., Barrón, Z.L. Zatarain, Rojas, L.L., Corrales, L., Martin, C., Barrón, F., Sotelo, C., Rodriguez, J., Ricaurte, L., Freitas, H., De Lima, V. Cordeiro, Mas, L., Ávila, J., Bravo, M., Mayorga, D., Archila, P., Otero, J., Carranza, H., Vargas, C., Rosell, R.

Get full text

P1.14-61 EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions by Cardona, A.F., Arrieta, O.G., Ruiz-Patiño, A., Barrón, Z.L. Zatarain, Rojas, L.L., Corrales, L., Martin, C., Barrón, F., Sotelo, C., Rodriguez, J., Ricaurte, L., Ávila, J., Mayorga, D., Archila, P., Otero, J., Freitas, H., De Lima, V. Cordeiro, Mas, L., Carranza, H., Vargas, C., Rosell, R.

Get full text

EP1.04-45 Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced NSCLC (CLICAP-ABs) by Barrón, F., Arrieta, O.G., Cardona, A.F., Ruiz-Patiño, A., Barrón, Z.L. Zatarain, Rojas, L.L., Corrales, L., Martin, C., Sotelo, C., Rodriguez, J., Ávila, J., Bravo, M., Mayorga, D., Archila, P., Mas, L., Freitas, H., De Lima, V. Cordeiro, Otero, J., Carranza, H., Vargas, C., Rosell, R.

Get full text

EP1.15-29 Real World Characterization and Treatment of Patients with Thymic Carcinoma: Lessons from a Latin-American Study (CLICaP-LATimus) by Mas, L., Patané, A., Arrieta, O.G., Soria, T., Cardona, A.F., Martin, C., Ruiz-Patiño, A., Rojas, L.L., Ruiz, R., Rioja, P., Lozano, S., Barrón, Z.L. Zatarain, Corassa, M., Freitas, H., De Lima, V. Cordeiro, Corrales, L., Sotelo, C., Rodriguez, J., Ricaurte, L., Ávila, J., Bravo, M., Mayorga, D., Archila, P., Otero, J., Carranza, H., Vargas, C., Rosell, R., Remon, J.

Get full text

EP1.15-28 Survival of Thymoma Is Extensive in Latin-American Patients: Results from Over 10 Years of Experience (CLICaP-LATimus) by Mas, L., Patané, A., Arrieta, O.G., Soria, T., Cardona, A.F., Martin, C., Ruiz-Patiño, A., Rojas, L.L., Ruiz, R., Rioja, P., Lozano, S., Barrón, Z.L. Zatarain, Corassa, M., Freitas, H., De Lima, V. Cordeiro, Corrales, L., Sotelo, C., Rodriguez, J., Ricaurte, L., Ávila, J., Mayorga, D., Bravo, M., Archila, P., Otero, J., Carranza, H., Vargas, C., Rosell, R., Remon, J.

Get full text

P1.04-81 Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy by Arrieta, O.G., Ruiz-Patiño, A., Cardona, A.F., Martin, C., Raez, L., Barrón, Z.L. Zatarain, Barrón, F., Ricaurte, L., Bravo-Garzón, M.A., Mas, L., Corrales, L., Rojas, L.L., Lupinacci, L., Perazzo, F., Bas, C., Carranza, O., Puparelli, C., Rizzo, M., Ruiz, R., Rolfo, C., Archila, P., Rodriguez, J., Sotelo, C., Vargas, C., Carranza, H., Otero, J., Pino, L., Ortiz, C., Laguado, P., Rosell, R.

Get full text

P1.04-80 Immunotherapy-Related Thrombosis: Considerations and Associated Factors in Non-Small Cell Lung Cancer (NSCLC) Patients by Cardona, A.F., Arrieta, O.G., Ruiz-Patiño, A., Barrón, Z.L. Zatarain, Rojas, L.L., Corrales, L., Martin, C., Barrón, F., Sotelo, C., Rodriguez, J., Ricaurte, L., Ávila, J., Bravo, M., Mayorga, D., Archila, P., Freitas, H., De Lima, V. Cordeiro, Mas, L., Otero, J., Carranza, H., Vargas, C., Rosell, R.

Get full text

EP1.04-46 Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP) by Cardona, A.F., Ruiz-Patiño, A., Arrieta, O.G., Martin, C., Raez, L., Barrón, Z.L. Zatarain, Barrón, F., Ricaurte, L., Bravo-Garzón, M.A., Mas, L., Corrales, L., Rojas, L.L., Lupinacci, L., Perazzo, F., Bas, C., Carranza, O., Puparelli, C., Rizzo, M., Ruiz, R., Rolfo, C., Archila, P., Rodriguez, J., Sotelo, C., Vargas, C., Carranza, H., Otero, J., Pino, L., Ortiz, C., Laguado, P., Rosell, R.

Get full text

P1.01-117 Pulmonary Function Monitoring in Patients with Oligometastatic NSCLC Who Receive Stereotactic Body Radiation Therapy by Arroyo-Hernandez, M., Blake-Cerda, M., Gochicoa-Rangel, L., Monraz-Pérez, S., Góngora, M.F. Cuevas, Bautista, D. Valle, Castillo, P.A. Barragán, Magos, F. Maldonado, Rodríguez, O., Flores, D., Arrieta, O.G.

Get full text